Clinical Trials Directory

Trials / Terminated

TerminatedNCT01756690

Predicting Lung Injury From Transfusion in Patients With Liver Disease

Endogenous Heparinoid Interference With Coagulation on Thromboelastogram as a Predictive Biomarker for Transfusion Related Acute Lung Injury (TRALI)

Status
Terminated
Phase
Study type
Observational
Enrollment
16 (actual)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

A certain molecule floating in the blood may represent a risk of lung injury after a transfusion. We are determining whether detection of this molecule on a simple blood clotting test will predict the development of lung injury due to transfusion in bleeding patients with chronic liver disease.

Conditions

Timeline

Start date
2011-10-01
Primary completion
2014-10-01
Completion
2016-12-01
First posted
2012-12-27
Last updated
2017-01-30

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01756690. Inclusion in this directory is not an endorsement.

Predicting Lung Injury From Transfusion in Patients With Liver Disease (NCT01756690) · Clinical Trials Directory